Joshua Hill, MD

@JoshuaHillMD

Infectious diseases physician and researcher with a focus on viral infections in immunocompromised hosts, work at , , . Opinions are my own.

Seattle, WA
Vrijeme pridruživanja: listopad 2013.

Tweetovi

Blokirali ste korisnika/cu @JoshuaHillMD

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @JoshuaHillMD

  1. proslijedio/la je Tweet
    19. pro 2019.

    Our statement on why community vaccine rates are so important to cancer & transplant patients Led by MS-3 & co-authored with my Pediatric colleague Dr. Paul Carpenter

    , , i još njih 7
    Prikaži ovu nit
    Poništi
  2. proslijedio/la je Tweet
    19. pro 2019.

    Incredibly excited to share this work. Microbial cell-free DNA sequencing predicted bloodstream infection pathogens up to 3 days before onset of infection in immunocompromised children!!!

    Prikaži ovu nit
    Poništi
  3. proslijedio/la je Tweet
    11. pro 2019.

    📢IDS 2020 Summer Internship applications now open!📢 8-10 wk early stage mentorship to promote understanding of infectious diseases & commitment to detection, prevention & treatment of infectious diseases in the immunocompromised host 🌎🦠 Pls RT! 👉

    , , i još njih 7
    Prikaži ovu nit
    Poništi
  4. proslijedio/la je Tweet
    7. pro 2019.

    Patients whose cancers come back after CAR T cells are in a desperate situation w/few options. One possible strategy is a 2nd infusion of the same product. New data at show that this seems to help some pts, & IDs variables linked to better odds.

    Poništi
  5. proslijedio/la je Tweet
    4. pro 2019.

    Awareness is needed for MDs/PharmDs about this drug-drug interaction - impt work by Arianne Duong & | pharmacy teams (led by Dr Liu from ) Clinically significant drug interaction: letermovir and voriconazole

    Poništi
  6. proslijedio/la je Tweet
    23. stu 2019.

    Glad you like it! At least in 2019, we aren’t embarking on this blind: we know how molds infect heme-onc patients because of the DECADES of clinical & research experience we have to draw from. How do we apply these concepts to CART? Molds are still devastating

    Poništi
  7. proslijedio/la je Tweet
    23. stu 2019.

    CMV detection by quantitative PCR in fresh gastrointestinal (GI) mucosa is as useful as immunohistochemistry (IHC). PCR has the same sensitivity, specificity & predictive values as IHC. Quantitative PCR in gut is more reliable than IHC for CMV GI disease

    Poništi
  8. 20. stu 2019.

    How does CD19 CAR-T cell therapy affect antiviral humoral immunity? Check out our new study here: IVIG may not be routinely indicated but more work to be done to guide best clinical practice.

    , , i još njih 5
    Poništi
  9. proslijedio/la je Tweet
    6. stu 2019.

    Can we increase surface BCMA and augment anti-tumor efficacy of BCMA CAR T cells in MM with a gamma secretase inhibitor? Look forward to presenting our data at !

    Poništi
  10. proslijedio/la je Tweet

    Check out the article highlighting our recent collaborative work with and using anti-idiotypes.

    Poništi
  11. proslijedio/la je Tweet
    31. lis 2019.

    Measles vaccine ⬇️ deaths by more than would be expected by reduction in measles cases alone. Could the broad immunosuppressive effects of this infection be the reason? Incredibly important study by , just published in

    Poništi
  12. proslijedio/la je Tweet
    17. lis 2019.

    Fantastic work from from during here time assessing abx allergies in HCT and SOT patients - 🗝️ message is⏫number of beta lactam allergies reported & opportunities 4 evaluation pre-Tx - 🔥mentor Dr. Liu

    , , i još njih 7
    Prikaži ovu nit
    Poništi
  13. proslijedio/la je Tweet
    11. lis 2019.

    Incidence, Risk Factors &Outcomes of Idiopathic Pneumonia Syndrome (IPS) after Allo HSCT. The incidence of IPS is declining in a modern cohort of allogeneic-HCT recipients. TBI dose remains a significant risk factor for IPS development.

    Poništi
  14. proslijedio/la je Tweet

    NEW🔥 in OFID : Crowdsourcing the Top Reasons to Choose Infectious Diseases in the Age of Twitter.

    , , i još njih 5
    Prikaži ovu nit
    Poništi
  15. proslijedio/la je Tweet
    5. lis 2019.

    Important new paper presented as abstract at that is just today in by from & colleagues from

    Prikaži ovu nit
    Poništi
  16. proslijedio/la je Tweet
    5. lis 2019.

    Question is butyrate producing bacteria and always good? Provocative data

    Prikaži ovu nit
    Poništi
  17. proslijedio/la je Tweet

    This great graphic shows the profound positive impact of vaccines on human health

    Poništi
  18. proslijedio/la je Tweet

    virus expert Dr. Michael Boeckh will deliver the prestigious John F. Enders Lecture Oct. 5 at @IDWeek2019, an annual conference of doctors and researchers specializing in .

    Poništi
  19. proslijedio/la je Tweet
    1. lis 2019.

    Addressing gender bias in medicine! There is more work ahead so let’s keep pushing for change to make board certification as equitable as possible. .

    Poništi
  20. 1. lis 2019.

    Proud to support my wife and colleagues in their work addressing in medicine.

    , , i još njih 6
    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·